PRAME (preferentially expressed antigen in melanoma) is a cancer-testis antigen, firstly discovered in a patient with melanoma, that is expressed by several solid tumors (i.e., squamous cell lung carcinoma, medulloblastoma, renal cell carcinoma, and acute leukemia), including NB [37]. Here, PRAME is linked to melanoma.